BDS5_ANEVI
ID BDS5_ANEVI Reviewed; 76 AA.
AC P0DMX9;
DT 16-SEP-2015, integrated into UniProtKB/Swiss-Prot.
DT 16-SEP-2015, sequence version 1.
DT 25-MAY-2022, entry version 12.
DE RecName: Full=Kappa-actitoxin-Avd4e {ECO:0000303|PubMed:22683676};
DE Short=Kappa-AITX-Avd4e {ECO:0000303|PubMed:22683676};
DE AltName: Full=Antihypertensive protein BDS-5 {ECO:0000305};
DE AltName: Full=Blood depressing substance 5 {ECO:0000303|PubMed:21281459};
DE Short=BDS-5 {ECO:0000303|PubMed:21281459};
DE Flags: Precursor;
OS Anemonia viridis (Snakelocks anemone).
OC Eukaryota; Metazoa; Cnidaria; Anthozoa; Hexacorallia; Actiniaria;
OC Actiniidae; Anemonia.
OX NCBI_TaxID=51769;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA].
RX PubMed=19627569; DOI=10.1186/1471-2164-10-333;
RA Sabourault C., Ganot P., Deleury E., Allemand D., Furla P.;
RT "Comprehensive EST analysis of the symbiotic sea anemone, Anemonia
RT viridis.";
RL BMC Genomics 10:333-333(2009).
RN [2]
RP PROTEIN SEQUENCE OF 34-76, DISULFIDE BOND, MASS SPECTROMETRY, AND
RP 3D-STRUCTURE MODELING.
RX PubMed=29671760; DOI=10.3390/md16040134;
RA Loret E.P., Luis J., Nuccio C., Villard C., Mansuelle P., Lebrun R.,
RA Villard P.H.;
RT "A low molecular weight protein from the sea anemone anemonia viridis with
RT an anti-angiogenic activity.";
RL Mar. Drugs 16:0-0(2018).
RN [3]
RP NOMENCLATURE.
RX PubMed=21281459; DOI=10.1186/1471-2164-12-88;
RA Kozlov S., Grishin E.;
RT "The mining of toxin-like polypeptides from EST database by single residue
RT distribution analysis.";
RL BMC Genomics 12:88-88(2011).
RN [4]
RP NOMENCLATURE.
RX PubMed=22683676; DOI=10.1016/j.toxicon.2012.05.020;
RA Oliveira J.S., Fuentes-Silva D., King G.F.;
RT "Development of a rational nomenclature for naming peptide and protein
RT toxins from sea anemones.";
RL Toxicon 60:539-550(2012).
RN [5]
RP 3D-STRUCTURE MODELING, AND TISSUE SPECIFICITY.
RX PubMed=24177670; DOI=10.3390/md11114213;
RA Nicosia A., Maggio T., Mazzola S., Cuttitta A.;
RT "Evidence of accelerated evolution and ectodermal-specific expression of
RT presumptive BDS toxin cDNAs from Anemonia viridis.";
RL Mar. Drugs 11:4213-4231(2013).
CC -!- FUNCTION: Is member of a fraction that shows antiangiogenic activity,
CC since it inhibits human microvascular endothelial cells (HMEC)
CC tubulogenesis (PubMed:29671760). This protein could be a kunitz-type
CC inhibitor with a RGD motif that could block angiogenesis in binding on
CC integrins (Probable). Blocks Kv3 voltage-gated potassium channels (By
CC similarity). Reduces blood pressure (By similarity).
CC {ECO:0000250|UniProtKB:P11494, ECO:0000269|PubMed:29671760,
CC ECO:0000305|PubMed:29671760}.
CC -!- SUBCELLULAR LOCATION: Secreted {ECO:0000305}. Nematocyst {ECO:0000305}.
CC -!- TISSUE SPECIFICITY: Moderately expressed in the ectodermal tissue from
CC the distal and proximal tentacles, body wall, and oral disk.
CC {ECO:0000269|PubMed:24177670}.
CC -!- MASS SPECTROMETRY: Mass=4742; Method=MALDI;
CC Evidence={ECO:0000269|PubMed:29671760};
CC -!- MISCELLANEOUS: In contrast to BDS-1, may have an alpha-helix which
CC could be located at the C-terminal domain.
CC {ECO:0000305|PubMed:29671760}.
CC -!- SIMILARITY: Belongs to the sea anemone type 3 (BDS) potassium channel
CC toxin family. {ECO:0000305}.
CC -!- CAUTION: Opinions are divided on whether Anemonia viridis (Forsskal,
CC 1775) and Anemonia sulcata (Pennant, 1777) are separate species.
CC {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; FK720902; -; NOT_ANNOTATED_CDS; mRNA.
DR EMBL; FK737121; -; NOT_ANNOTATED_CDS; mRNA.
DR EMBL; FK755577; -; NOT_ANNOTATED_CDS; mRNA.
DR EMBL; FK758510; -; NOT_ANNOTATED_CDS; mRNA.
DR AlphaFoldDB; P0DMX9; -.
DR SMR; P0DMX9; -.
DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR GO; GO:0042151; C:nematocyst; IEA:UniProtKB-SubCell.
DR GO; GO:0008200; F:ion channel inhibitor activity; IEA:InterPro.
DR GO; GO:0015459; F:potassium channel regulator activity; IEA:UniProtKB-KW.
DR GO; GO:0090729; F:toxin activity; IEA:UniProtKB-KW.
DR GO; GO:0008217; P:regulation of blood pressure; IEA:UniProtKB-KW.
DR Gene3D; 2.20.20.10; -; 1.
DR InterPro; IPR012414; BDS_K_chnl_tox.
DR InterPro; IPR023355; Myo_ane_neurotoxin_sf.
DR Pfam; PF07936; Defensin_4; 1.
PE 1: Evidence at protein level;
KW Cleavage on pair of basic residues; Direct protein sequencing;
KW Disulfide bond; Hypotensive agent; Ion channel impairing toxin; Nematocyst;
KW Neurotoxin; Potassium channel impairing toxin; Secreted; Signal; Toxin;
KW Voltage-gated potassium channel impairing toxin.
FT SIGNAL 1..19
FT /evidence="ECO:0000255"
FT PROPEP 20..31
FT /evidence="ECO:0000305|PubMed:29671760"
FT /id="PRO_0000433654"
FT CHAIN 34..76
FT /note="Kappa-actitoxin-Avd4e"
FT /evidence="ECO:0000269|PubMed:29671760"
FT /id="PRO_0000433655"
FT MOTIF 45..47
FT /note="Cell attachment site"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00293"
FT DISULFID 37..72
FT /evidence="ECO:0000269|PubMed:29671760"
FT DISULFID 39..65
FT /evidence="ECO:0000269|PubMed:29671760"
FT DISULFID 55..73
FT /evidence="ECO:0000269|PubMed:29671760"
SQ SEQUENCE 76 AA; 8377 MW; 563C067E5399B741 CRC64;
MNKALFLCLV VLCAAVVFAA EDLQKAKHAP FKRAAPCFCS GKPGRGDLWI FRGTCPGGYG
YTSNCYKWPN ICCYPH
